By DENISE GRADY
Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
Published: April 15, 2018 at 08:00PM
from NYT Health https://ift.tt/2qGky4b
via IFTTT
from WordPress https://ift.tt/2vm92Am
via IFTTT
No comments:
Post a Comment